ProShares Ultra CRCL ETF Stock Price, News & Analysis
Company Description
ProShares Ultra CRCL ETF (NYSE: CRCA) is a publicly traded company.
CRCA stock has declined 81.2% over the past year. Shares last traded at $42.00.
This page provides a comprehensive overview of CRCA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ProShares Ultra CRCL ETF (CRCA) stock last traded at $42.00, down 1.76% from the previous close. Over the past 12 months, the stock has lost 81.2%.
Latest News
ProShares Ultra CRCL ETF has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CRCA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in ProShares Ultra CRCL ETF (CRCA) currently stands at 183.2 thousand shares, up 316.3% from the previous reporting period, representing 4.7% of the float. Over the past 12 months, short interest has decreased by 65.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for ProShares Ultra CRCL ETF (CRCA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.